A detailed history of Two Sigma Investments, LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 136,777 shares of TXG stock, worth $3.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
136,777
Previous 43,352 215.5%
Holding current value
$3.09 Million
Previous $1.63 Million 63.49%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.45 - $37.37 $1.82 Million - $3.49 Million
93,425 Added 215.5%
136,777 $2.66 Million
Q1 2024

May 15, 2024

BUY
$36.08 - $54.3 $59,604 - $89,703
1,652 Added 3.96%
43,352 $1.63 Million
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $394,680 - $661,825
11,500 Added 38.08%
41,700 $2.33 Million
Q3 2023

Nov 14, 2023

SELL
$40.86 - $62.98 $4.89 Million - $7.54 Million
-119,687 Reduced 79.85%
30,200 $1.25 Million
Q2 2023

Aug 14, 2023

BUY
$50.96 - $58.72 $6.36 Million - $7.33 Million
124,787 Added 497.16%
149,887 $8.37 Million
Q1 2023

May 15, 2023

SELL
$35.33 - $55.79 $7.44 Million - $11.7 Million
-210,543 Reduced 89.35%
25,100 $1.4 Million
Q4 2022

Feb 14, 2023

SELL
$24.4 - $41.3 $2.92 Million - $4.94 Million
-119,525 Reduced 33.65%
235,643 $8.59 Million
Q3 2022

Nov 14, 2022

BUY
$28.48 - $52.59 $5.77 Million - $10.7 Million
202,762 Added 133.04%
355,168 $10.1 Million
Q2 2022

Aug 15, 2022

BUY
$36.95 - $82.41 $3.27 Million - $7.28 Million
88,368 Added 137.99%
152,406 $6.9 Million
Q1 2022

May 16, 2022

BUY
$55.7 - $145.79 $3.57 Million - $9.34 Million
64,038 New
64,038 $4.87 Million
Q2 2021

Aug 16, 2021

SELL
$134.22 - $202.37 $11.5 Million - $17.4 Million
-85,921 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$140.25 - $196.86 $2.19 Million - $3.08 Million
15,621 Added 22.22%
85,921 $15.6 Million
Q4 2020

Feb 16, 2021

BUY
$126.47 - $163.7 $8.89 Million - $11.5 Million
70,300 New
70,300 $9.95 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $2.15B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.